Public Sector Pension Investment Board Acquires 207,070 Shares of HCA Healthcare, Inc. $HCA

Public Sector Pension Investment Board raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 127.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 369,704 shares of the company’s stock after acquiring an additional 207,070 shares during the quarter. Public Sector Pension Investment Board owned approximately 0.16% of HCA Healthcare worth $157,568,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Norges Bank purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at about $1,152,408,000. Pacer Advisors Inc. lifted its holdings in HCA Healthcare by 6,115.3% during the third quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock valued at $388,309,000 after purchasing an additional 896,437 shares in the last quarter. Viking Global Investors LP increased its stake in shares of HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at $109,337,000. Finally, HRT Financial LP bought a new stake in HCA Healthcare during the second quarter valued at about $81,596,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Zacks Research raised FY-2026 EPS to $29.31 (from $28.47) and lifted multiple quarterly and multi‑year estimates (FY2027 to $33.44, FY2028 to $37.67), aligning analyst expectations with HCA’s FY2026 guidance and suggesting stronger forward profitability. Zacks remains at a “Hold” rating, but the higher estimates support valuation and earnings momentum. Zacks estimate changes (MarketBeat)
• Neutral Sentiment: HCA’s StoneSprings Hospital Center is planning to convert a Chantilly deli site into a freestanding emergency room — a local expansion that could modestly increase patient volumes and admissions in that market over time. HCA StoneSprings freestanding ER
• Neutral Sentiment: HCA-related ASC real estate was sold, a move that can free capital or change lease/operating dynamics for ambulatory surgery centers; the net effect depends on deal terms and use of proceeds. HCA ASC real estate sold
• Neutral Sentiment: Executive moves: a former HCA Florida executive joined Memorial Health as COO and an HCA veteran was named COO at Memorial Health in Georgia — routine industry leadership turnover that may have limited near‑term impact on HCA’s financials but is notable for regional competitive dynamics and management talent flow. Former HCA exec joins Memorial Health (MSN) HCA veteran named COO (Becker’s)

HCA Healthcare Price Performance

Shares of HCA stock opened at $535.24 on Friday. The company has a market cap of $119.69 billion, a PE ratio of 18.86, a price-to-earnings-growth ratio of 1.63 and a beta of 1.36. The stock’s 50 day simple moving average is $481.73 and its two-hundred day simple moving average is $446.85. HCA Healthcare, Inc. has a 1 year low of $295.00 and a 1 year high of $552.90.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter in the prior year, the firm posted $6.22 EPS. HCA Healthcare’s quarterly revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a $0.78 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 10.15%.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the transaction, the senior vice president owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total value of $747,135.00. Following the transaction, the executive vice president owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 13,520 shares of company stock worth $6,894,067 over the last 90 days. Company insiders own 1.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Zacks Research downgraded HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. Cantor Fitzgerald boosted their target price on shares of HCA Healthcare from $525.00 to $588.00 and gave the stock an “overweight” rating in a report on Wednesday, January 28th. Truist Financial lifted their price target on shares of HCA Healthcare from $520.00 to $546.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Jefferies Financial Group raised their price objective on HCA Healthcare from $535.00 to $590.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Finally, The Goldman Sachs Group raised their price target on HCA Healthcare from $520.00 to $558.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $523.27.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.